Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 8:35 AM EDT

149.92

+0.01 (+0.01%)

Volume

4,621

149.91UNCH (UNCH)

52 week range

143.13 - 175.97

Open0.00
Day High0.00
Day Low0.00
Prev Close149.91
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24

Key Stats

Market Cap360.785B
Shares Out2.41B
10 Day Average Volume7.71M
Dividend4.96
Dividend Yield3.31%
Beta0.53
YTD % Change-4.36

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close149.91
52 Week High175.97
52 Week High Date08/10/23
52 Week Low143.13
52 Week Low Date04/18/24
Market Cap360.785B
Shares Out2.41B
10 Day Average Volume7.71M
Dividend4.96
Dividend Yield3.31%
Beta0.53
YTD % Change-4.36

RATIOS/PROFITABILITY

EPS (TTM)6.69
P/E (TTM)22.41
Fwd P/E (NTM)14.19
EBITDA (TTM)31.292B
ROE (TTM)24.23%
Revenue (TTM)85.648B
Gross Margin (TTM)69.57%
Net Margin (TTM)19.93%
Debt To Equity (MRQ)48.03%

EVENTS

Earnings Date07/17/2024(est)
Ex Div Date05/20/2024
Div Amount1.24
Split Date-
Split Factor-

Latest On Johnson & Johnson

Stocks making the biggest moves premarket: GameStop, Nvidia, Intel, Kenvue1 Hour AgoCNBC.com
TRADE ALERTWe're exiting a troubled drugmaker and buying 2 stocks with brighter outlooksMay 8, 2024CNBC.com
Lightning Round: Hard pass on C3.ai, says Jim CramerMay 7, 2024CNBC.com
Cramer's thoughts on AMD, Johnson & Johnson, CVS Health, Super Micro and PinterestMay 1, 2024CNBC.com
Wednesday’s rapid fire: AMD, Johnson & Johnson, CVS Health, Super Micro and PinterestMay 1, 2024CNBC.com

Content From Our Affiliates

Rani Therapeutics price target raised to $14 from $7 at BTIGMay 9, 2024TipRanks
Hold Rating on Johnson & Johnson Amid Varipulse PFA Catheter Recall and Approval UncertaintiesMay 9, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Johnson & Johnson (JNJ) and Hims & Hers Health (HIMS)May 7, 2024TipRanks
Johnson & Johnson: Navigating Legal Challenges with a Strategic Settlement OutlookMay 7, 2024TipRanks
Johnson & Johnson (JNJ) Receives a Buy from Cantor FitzgeraldMay 7, 2024TipRanks

Profile

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...

Joaquin Duato

Chairman of the Board, Chief Executive Officer

Joseph Wolk

Chief Financial Officer, Executive Vice President

Tim Schmid

Executive Vice President, Worldwide Chairman of MedTech

Elizabeth Forminard

Executive Vice President, General Counsel

John Reed M.D., Ph.D.

Executive Vice President - Innovative Medicine, Research and Development

Address

One Johnson & Johnson Plaza

New Brunswick, NJ

08933

United States

https://www.jnj.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
MRK Merck & Co Inc	130.06	UNCH	UNCH
ABBV AbbVie Inc	160.75	UNCH	UNCH
AZN AstraZeneca PLC	77.18	UNCH	UNCH
RHHBY Roche Holding AG	30.95	UNCH	UNCH
NVS Novartis AG	102.10	UNCH	UNCH